Current Report Filing (8-k)
June 26 2020 - 4:31PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 22, 2020
89bio, Inc.
(Exact name
of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-39122
|
|
36-4946844
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
142 Sansome Street, Second Floor
San Francisco, CA 94104
(Address of Principal Executive Offices, and Zip Code)
(415) 500-4614
(Registrants Telephone Number, Including Area Code)
Not applicable
(Former
Name or Former Address, if Changed Since Last Report)
Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
☐
|
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
Common Stock, par value $0.001 per share
|
|
ETNB
|
|
The Nasdaq Global Market
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act
of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR § 240.12b-2).
Emerging growth company ☒
If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item 5.07.
|
Submission of Matters to a Vote of Security Holders.
|
On Monday, June 22, 2020, 89bio, Inc. (the Company) held its 2020 Annual Meeting of Stockholders (the 2020 Annual
Meeting) at 9:00 a.m., Pacific Time. As of the close of business on April 30, 2020, the record date for the 2020 Annual Meeting, there were 13,793,858 shares of common stock entitled to vote at the meeting. At the 2020 Annual Meeting,
each of the Companys director nominees was elected and the other proposal voted on was approved. The final voting results are set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Votes
For
|
|
|
Votes
Withheld
|
|
|
Broker
Non-Votes
|
|
Proposal 1. Election of Class I Directors
|
|
|
|
|
|
|
|
|
|
|
|
|
Rohan Palekar
|
|
|
11,921,014
|
|
|
|
465,390
|
|
|
|
317,113
|
|
Gregory Grunberg, M.D.
|
|
|
11,727,580
|
|
|
|
658,824
|
|
|
|
317,113
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Votes
For
|
|
|
Votes
Against
|
|
|
Abstentions
|
|
|
Broker
Non-Votes
|
|
Proposal 2. Ratification of KPMG LLP
as Independent Auditor
|
|
|
12,703,246
|
|
|
|
0
|
|
|
|
271
|
|
|
|
0
|
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
89bio, Inc.
|
|
|
|
|
Date: June 26, 2020
|
|
|
|
By:
|
|
/s/ Rohan Palekar
|
|
|
|
|
|
|
Rohan Palekar
|
|
|
|
|
|
|
Chief Executive Officer
|
89bio (NASDAQ:ETNB)
Historical Stock Chart
From Aug 2024 to Sep 2024
89bio (NASDAQ:ETNB)
Historical Stock Chart
From Sep 2023 to Sep 2024